BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12477069)

  • 1. Power and sample size determination for noninferiority trials using an exact method.
    Chan IS
    J Biopharm Stat; 2002 Nov; 12(4):457-69. PubMed ID: 12477069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring rare serious adverse events from a new treatment and testing for a difference from historical controls.
    Fay MP; Huang CY; Twum-Danso NA
    Clin Trials; 2007; 4(6):598-610. PubMed ID: 18042569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
    Lui KJ; Chang KC
    Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size and optimal designs in stratified comparative trials to establish the equivalence of treatment effects among two ethnic groups.
    Chen YH; Wang M
    J Biopharm Stat; 2002 Nov; 12(4):553-66. PubMed ID: 12477074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approximate unconditional test of non-inferiority between two proportions.
    Kang SH; Chen JJ
    Stat Med; 2000 Aug; 19(16):2089-100. PubMed ID: 10931513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative sample size estimation in nonparametrics.
    De Martini D
    J Biopharm Stat; 2011 Jan; 21(1):24-41. PubMed ID: 21191852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the instrumental variables estimator to analyze noninferiority trials with noncompliance.
    Kim MY
    J Biopharm Stat; 2010 Jul; 20(4):745-58. PubMed ID: 20496203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y; Chen WJ
    J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stopping boundaries adjusted for sample size reestimation and negative stop.
    Shun Z
    J Biopharm Stat; 2002 Nov; 12(4):485-502. PubMed ID: 12477071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial design for assessing noninferiority when superiority is expected.
    Freidlin B; Korn EL; George SL; Gray R
    J Clin Oncol; 2007 Nov; 25(31):5019-23. PubMed ID: 17971602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review.
    Sahai H; Khurshid A
    Stat Med; 1996 Jan; 15(1):1-21. PubMed ID: 8614740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exact inference for matched case-control studies.
    Hirji KF; Mehta CR; Patel NR
    Biometrics; 1988 Sep; 44(3):803-14. PubMed ID: 3203129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I error and power in noninferiority/equivalence trials with correlated multiple endpoints: an example from vaccine development trials.
    Kong L; Kohberger RC; Koch GG
    J Biopharm Stat; 2004 Nov; 14(4):893-907. PubMed ID: 15587971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample sizes based on exact unconditional tests for phase II clinical trials with historical controls.
    Chang MN; Shuster JJ; Kepner JL
    J Biopharm Stat; 2004 Feb; 14(1):189-200. PubMed ID: 15027508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimization of sample size when comparing two small probabilities in a non-inferiority safety trial.
    de Boo TM; Zielhuis GA
    Stat Med; 2004 Jun; 23(11):1683-99. PubMed ID: 15160402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.